Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0000905148-20-000732

Options or other derivatives

  • Director acquired 7,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peters Richard Director 2020-06-26 Grant or award · Stock Option (right to Buy) +7,000 7,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…